Evidence map›Paper›PMID 41432552›Full record

ArticleMicrobiology spectrum2026

Emergence of coexisting

Shuang Wang, Lu Liu, Lei Du, Shanli Gao, Xiaolin Yu, Lixiao Cheng, Yuzhen Chen, Zengqiang Kou, Wenkui Sun

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuang Wang *Infection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.ORCID 0000-0002-9543-8739
Lu Liu *Infection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.ORCID 0009-0001-6057-6015
Lei DuDivision of Liver Diseases, Shandong Public Health Clinical Center, Jinan, China.
Shanli GaoCentral Office, Zhucheng Center for Disease Control and Prevention, Weifang, China.
Xiaolin YuInfection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.
Lixiao ChengInfection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.
Yuzhen ChenInfection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.
Zengqiang KouInfection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.ORCID 0009-0006-2879-5855
Wenkui SunInfection Disease Control of Institute, Shandong Center for Disease Control and Prevention, Jinan, China.ORCID 0000-0001-7499-2450

Funding

Department of Science and Technology of Shandong Province 2017GSF218062, ZR2024MH289Health and Family Planning Commission of Shandong Province 2017WS105Health and Family Planning Commission of Shandong Province 202112071042, 202312050986Health and Family Planning Commission of Shandong Province 202412051230
6 · The paper itself

Abstract

The emergence of IMPORTANCE: This study reports isolation of

Indexed as

beta-LactamasesEscherichia coliEscherichia coli ProteinsAnti-Bacterial AgentsChinaDrug Resistance, Multiple, BacterialEscherichia coli InfectionsFemaleHealthy VolunteersHumansMicrobial Sensitivity TestsPlasmidsPolymorphism, Single NucleotideTigecyclineWhole Genome SequencingAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesEscherichia coli ProteinsMCR-1 protein, E coliTigecyclinedrug resistanceEscherichia colihealthy individualsmcr-1NDM

Identifiers

PMID41432552
PMCPMC12889101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.